Find out more about Guillaume Lessene's experience
Guillaume Lessene's highlights
FEATURED Journal article
Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia.
Read moreGuillaume Lessene's selected work
Stopping healthy cells from self-destructing
NEWS ARTICLE
Cotargeting BCL-2 and MCL-1 in high-risk B-ALL
Journal article
Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mu..
Journal article
Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical m..
Journal article
BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines
Journal article
Enhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1
Journal article
Guillaume Lessene's selected work
Scholarly Works
Displaying the 10 most recent scholarly works from 91 for Guillaume Lessene.
News
Displaying the 1 most recent news article from 1 for Guillaume Lessene.
Credentials
Positions
Honorary
Medical Biology (w.e.h.i.)
Honorary
Biochemistry and Pharmacology
Honorary
Medical Biology (w.e.h.i.)